Lingamneni Anila 4
4 · HAEMONETICS CORP · Filed Jul 15, 2024
Insider Transaction Report
Form 4
Lingamneni Anila
EVP, Chief Technology Officer
Transactions
- Sale
Common Stock
2024-07-11$90.00/sh−2,136$192,240→ 21,410 total - Sale
Common Stock
2024-07-12$90.00/sh−79$7,110→ 21,331 total
Footnotes (2)
- [F1]Transaction pursuant to an existing 10b5-1 trading plan dated March 13, 2024 (fully executed as of March 13, 2024).
- [F2]This number includes unvested restricted stock units previously reported.